ODDB.org: Open Drug Database

Home - 53161 - 06 - 006

Sandostatin LAR 30 mg Fertigspritzen, Injektionspräparat - 30 mg

Swissmedic Key	53161006	Registration Holder	Novartis Pharma Schweiz AG
Name	Sandostatin LAR 30 mg Fertigspritzen, Injektionspräparat	Date of registration	29.08.1995
Original/Generic	Original	Introduction of Sequence	02.10.2003
ATC-Classification	Octreotide (H01CB02)	Revision date	02.11.2004
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.20.	Show package size	30 mg
Index Therapeuticus (Swissmedic)	07.16.20.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	1265.46	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	1377.85
Feedback	FB
GTIN	7680531610065	Medication Code	Synthetika
Pharmacode	7174447	Disponibility

Composition

Praeparatio sicca: octreotidum 30 mg ut octreotidi acetas 33.6 mg, poly(lactidum-co-glycolidum), mannitolum, pro vitro. Solvens: carmellosum natricum corresp. natrium 1.512 mg, mannitolum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 2.0 ml.

Packungsbestandteile

Galenic Form

Injection preparation

Excipiens

Active Agent	Dose	additional_information
Octreotide	30 mg	Praeparatio sicca

BAG: Active Agent	Dose
Octreotide	30 mg

Inactive agents
Mannitol
Poly(Lactidum-Co-Glycolidum)

Label

Solvens

Galenic Form

Injection preparation

Excipiens

BAG: Active Agent	Dose
Octreotide	30 mg

Inactive agents	Dose
Carmellose Sodium
Mannitol
Poloxamer	188

Source

Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH